| List | Section | Observation |
|---|---|---|
| WHO Model List of Essential Medicines (2021) | 6.5.4. Antipneumocystosis and antitoxoplasmosis medicines | No observations |
| PAHO Strategic Fund Medicine List | 2.7.3. Antipneumocystosis and antitoxoplasmosis medicines | No observations |
| Peru | 6.5.4 Anti-Pneumocystis and Anti-Toxoplasmosis | No observations |
| WHO Model List of Essential Medicines (2021) | 6.2.1. Access group antibiotics |
Others observations: FIRST CHOICE − Lower urinary tract infections SECOND CHOICE − Acute invasive diarrhoea / bacterial dysentery |
| PAHO Strategic Fund Medicine List | 2.1. Antibacterial | No observations |
| List | Section | Observation |
|---|---|---|
| WHO Model List of Essential Medicines (2021) | 6.5.4. Antipneumocystosis and antitoxoplasmosis medicines | No observations |
| PAHO Strategic Fund Medicine List | 2.7.3. Antipneumocystosis and antitoxoplasmosis medicines | No observations |
| Peru | 6.2.2.3 Sulfonamides with Diaminopyrimidines | No observations |
| Chile | Essential and Prioritized Medications | No observations |
| WHO Model List of Essential Medicines (2021) | 6.2.1. Access group antibiotics |
Others observations: FIRST CHOICE − Lower urinary tract infections SECOND CHOICE − Acute invasive diarrhoea / bacterial dysentery |
| PAHO Strategic Fund Medicine List | 2.1. Antibacterial | No observations |
| List | Section | Observation |
|---|---|---|
| WHO Model List of Essential Medicines (2021) | 6.5.4. Antipneumocystosis and antitoxoplasmosis medicines |
This medicine is only for children. |
| PAHO Strategic Fund Medicine List | 2.7.3. Antipneumocystosis and antitoxoplasmosis medicines | No observations |
| Bolivia | LINAME 2011 - 2013 | No observations |
| Peru | 6.2.2.3 Sulfonamides with Diaminopyrimidines | No observations |
| Ecuador | Essential Medicines List - Ecuador | No observations |
| Chile | Essential and Prioritized Medications | No observations |
| Colombia | 06. Acute Respiratory Infections | No observations |
| Venezuela (incomplete) | List of Generic Medications - Venezuela | No observations |
| WHO Model List of Essential Medicines (2021) | 6.2.1. Access group antibiotics |
Others observations: FIRST CHOICE − Lower urinary tract infections SECOND CHOICE − Acute invasive diarrhoea / bacterial dysentery |
| PAHO Strategic Fund Medicine List | 2.1. Antibacterial | No observations |
| List | Section | Observation |
|---|---|---|
| Cuba | 6.2.7 Sulfonamidas | No observations |
| List | Section | Observation |
|---|---|---|
| Bolivia | LINAME 2011 - 2013 | No observations |
| List | Section | Observation |
|---|---|---|
| WHO Model List of Essential Medicines (2021) | 6.5.4. Antipneumocystosis and antitoxoplasmosis medicines | No observations |
| PAHO Strategic Fund Medicine List | 2.1. Antibacterial | No observations |
| PAHO Strategic Fund Medicine List | 2.7.3. Antipneumocystosis and antitoxoplasmosis medicines | No observations |
| Bolivia | LINAME 2011 - 2013 | No observations |
| WHO Model List of Essential Medicines (2021) | 6.2.1. Access group antibiotics |
Others observations: FIRST CHOICE − Lower urinary tract infections SECOND CHOICE − Acute invasive diarrhoea / bacterial dysentery |
| List | Section | Observation |
|---|---|---|
| WHO Model List of Essential Medicines (2021) | 6.5.4. Antipneumocystosis and antitoxoplasmosis medicines |
This medicine is only for children. |
| PAHO Strategic Fund Medicine List | 2.1. Antibacterial | No observations |
| PAHO Strategic Fund Medicine List | 2.7.3. Antipneumocystosis and antitoxoplasmosis medicines | No observations |
| Bolivia | LINAME 2011 - 2013 | No observations |
| Peru | 6.2.2.3 Sulfonamides with Diaminopyrimidines | No observations |
| Ecuador | Essential Medicines List - Ecuador | No observations |
| Chile | Essential and Prioritized Medications | No observations |
| Colombia | 03.1 Antibacterials | No observations |
| Cuba | 6.2.7 Sulfonamidas | No observations |
| WHO Model List of Essential Medicines (2021) | 6.2.1. Access group antibiotics |
Others observations: FIRST CHOICE − Lower urinary tract infections SECOND CHOICE − Acute invasive diarrhoea / bacterial dysentery |
| List | Section | Observation |
|---|---|---|
| WHO Model List of Essential Medicines (2021) | 6.5.4. Antipneumocystosis and antitoxoplasmosis medicines | No observations |
| PAHO Strategic Fund Medicine List | 2.1. Antibacterial | No observations |
| PAHO Strategic Fund Medicine List | 2.7.3. Antipneumocystosis and antitoxoplasmosis medicines | No observations |
| Bolivia | LINAME 2011 - 2013 | No observations |
| Peru | 6.2.2.3 Sulfonamides with Diaminopyrimidines | No observations |
| Peru | 6.5.4 Anti-Pneumocystis and Anti-Toxoplasmosis | No observations |
| Chile | Essential and Prioritized Medications | No observations |
| Colombia | 03.1 Antibacterials | No observations |
| WHO Model List of Essential Medicines (2021) | 6.2.1. Access group antibiotics |
Others observations: FIRST CHOICE − Lower urinary tract infections SECOND CHOICE − Acute invasive diarrhoea / bacterial dysentery |